Atlas Trials

ESCC

26 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch ESCC

RecordFirmDate
Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer (NCT07015489)The First Affiliated Hospital with Nanjing Medical University2022-01-01
Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants (NCT04939701)Astellas Pharma Global Development, Inc.2021-12-23
DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer (NCT05050760)Xijing Hospital2021-09-01
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors (NCT04686682)Jacobio Pharmaceuticals Co., Ltd.2021-05-07
Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 ) (NCT04863079)Tianjin Medical University Cancer Institute and Hospital2021-05-01
TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer (NCT04471480)Dong Wang2020-09-01
Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR） (NCT06478355)Hebei Medical University Fourth Hospital2018-01-01

Track ESCC automatically

Every clearance here is in the API, with alerts when new ones post.